Frailty Index and Cognitive Decline in Alzheimer's Disease: Data from the Impact of Cholinergic Treatment USe Study

Journal of the American Geriatrics Society

Volumn 64, Issue 6, 2016, Pages 1165-1170

  Kelaiditi, Eirini ^a   Canevelli, Marco ^a,b   Andrieu, Sandrine ^a,c,d   Del Campo, Natalia ^a   Soto, Maria E ^a,c   Vellas, Bruno ^a,c,d   Cesari, Matteo ^a,c,d  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSERM   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Alzheimer's disease; cognition; dementia; Frailty Index; longitudinal analysis

Indexed keywords

CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL DEMENTIA RATING; COGNITION ASSESSMENT; COHORT ANALYSIS; DISEASE SEVERITY ASSESSMENT; FEMALE; FRAILTY INDEX; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; PROSPECTIVE STUDY;

EID: 84975261027     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13956     Document Type: Article

References (38)

1. World Alzheimer Report 2013. Journey of Caring. An Analysis of Long-Term Care for Dementia. London: Alzheimer's Disease International, 2013.
2. Cesari M, Abellan van Kan G, Ariogul J, et al. The European Union Geriatric Medicine Society (EUGMS) working group on “Frailty in older persons”. J Frailty Aging 2013;2:118–120.
3. Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: A call to action. J Am Med Dir Assoc 2013;14:392–397.
4. Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013;381:752–762.
5. Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J 2005;173:489–495.
6. Cesari M, Gambassi G, van Kan GA, et al. The frailty phenotype and the frailty index: Different instruments for different purposes. Age Ageing 2014;43:10–12.
7. Gray SL, Anderson ML, Hubbard RA, et al. Frailty and incident dementia. J Gerontol A Biol Sci Med Sci 2013;68A:1083–1090.
8. Auyeung TW, Lee JS, Kwok T, et al. Physical frailty predicts future cognitive decline—a four-year prospective study in 2737 cognitively normal older adults. J Nutr Health Aging 2011;15:690–694.
9. Mitnitski A, Fallah N, Rockwood MRH, et al. Transitions in cognitive status in relation to frailty in older adults: A comparison of three frailty measures. J Nutr Health Aging 2011;15:863–867.
10. Jacobs J, Cohen A, Ein-Mor E, et al. Frailty, cognitive impairment and mortality among the oldest old. J Nutr Health Aging 2011;15:678–682.
11. Boyle PA, Buchman AS, Wilson RS, et al. Physical frailty is associated with incident mild cognitive impairment in community-based older persons. J Am Geriatr Soc 2010;58:248–255.
12. Buchman AS, Boyle PA, Wilson RS, et al. Frailty is associated with incident Alzheimer's disease and cognitive decline in the elderly. Psychosom Med 2007;69:483–489.
13. Macuco CRM, Batistoni SST, Lopes A, et al. Mini-Mental State Examination performance in frail, pre-frail, and non-frail community dwelling older adults in Ermelino Matarazzo, São Paulo, Brazil. Int Psychogeriatr 2012;24:1725–1731.
14. Yassuda M, Lopes A, Cachioni M, et al. Frailty criteria and cognitive performance are related: Data from the Fibra study in Ermelino Matarazzo, Sao Paulo, Brazil. J Nutr Health Aging 2012;16:55–61.
15. Mitnitski A, Fallah N, Rockwood K. A multistate model of cognitive dynamics in relation to frailty in older adults. Ann Epidemiol 2011;21:507–516.
16. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007;62A:722–727.
17. Schmidt C, Wolff M, Weitz M, et al. Rapidly progressive Alzheimer disease. Arch Neurol 2011;68:1124–1130.
18. Mitnitski AB, Fallah N, Dean CB, et al. A multi-state model for the analysis of changes in cognitive scores over a fixed time interval. Stat Methods Med Res 2011;23:244–256.
19. Reynish E, Cortes F, Andrieu S, et al. The ICTUS study: A prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology 2007;29:29–38.
20. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–944.
21. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
22. Canevelli M, Adali N, Kelaiditi E, et al. Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study. Phytomedicine 2014;21:888–892.
23. Kato Y, Narumoto J, Matsuoka T, et al. Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer's disease. Neuropsychiatr Dis Treat 2013;9:581–586.
24. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356–1364.
25. Vellas B, Andrieu S, Sampaio C, et al. Endpoints for trials in Alzheimer's disease: A European task force consensus. Lancet Neurol 2008;7:436–450.
26. Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993;43:2412–2414.
27. Ousset PJ, Nourhashemi F, Reynish E, et al. Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Dis Assoc Disord 2008;22:66–71.
28. Mitnitski A, Song X, Skoog I, et al. Relative fitness and frailty of elderly men and women in developed countries and their relationship with mortality. J Am Geriatr Soc 2005;53:2184–2189.
29. Searle SD, Mitnitski A, Gahbauer EA, et al. A standard procedure for creating a frailty index. BMC Geriatr 2008;8:24.
30. Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 2007;62A:738–743.
31. Rockwood K, Mitnitski A. Limits to deficit accumulation in elderly people. Mech Ageing Dev 2006;127:494–496.
32. Hensel A, Angermeyer MC, Riedel-Heller SG. Measuring cognitive change in older adults: Reliable change indices for the Mini-Mental State Examination. J Neurol Neurosurg Psychiatry 2007;78:1298–1303.
33. Lopez OL, Becker JT, Saxton J, et al. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition. J Am Geriatr Soc 2005;53:83–87.
34. Ito K, Ahadieh S, Corrigan B, et al. Disease progression meta-analysis model in Alzheimer's disease. Alzheimers Dement 2010;6:39–53.
35. Gillette-Guyonnet S, Andrieu S, Nourhashemi F, et al. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimers Dement 2011;7:579–592.
36. Fontana L, Kennedy BK, Longo VD. Medical research: Treat ageing. Nature 2014;511:405–407.
37. Kulminski AM, Ukraintseva SV, Kulminskaya IV, et al. Cumulative deficits better characterize susceptibility to death in elderly people than phenotypic frailty: Lessons from the Cardiovascular Health Study. J Am Geriatr Soc 2008;56:898–903.
38. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56A:M146–M156.